Latest Insider Transactions at Pmv Pharmaceuticals, Inc. (PMVP)
This section provides a real-time view of insider transactions for Pmv Pharmaceuticals, Inc. (PMVP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PMV Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PMV Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2021
|
Interwest Partners X LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
10,000
-100.0%
|
-
|
|
Mar 24
2021
|
Interwest Partners X LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,000,000
-15.46%
|
-
|
|
Mar 09
2021
|
David Henry Mack President and CEO |
BUY
Bona fide gift
|
Indirect |
40,000
+33.33%
|
-
|
|
Mar 09
2021
|
David Henry Mack President and CEO |
SELL
Bona fide gift
|
Indirect |
40,000
-21.29%
|
-
|
|
Dec 08
2020
|
Winston Kung COO, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+50.0%
|
$4,800
$3.22 P/Share
|
|
Nov 18
2020
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,470
+50.0%
|
$0
$0.53 P/Share
|
|
Sep 29
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
950,000
+35.71%
|
$17,100,000
$18.0 P/Share
|
|
Sep 29
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
760,265
+50.0%
|
-
|
|
Sep 29
2020
|
Euclidean Capital LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
4,179,416
+50.0%
|
-
|
|
Sep 29
2020
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,114,330
+25.36%
|
-
|
|
Sep 29
2020
|
Boxer Capital, LLC |
BUY
Conversion of derivative security
|
Indirect |
60,837
+40.81%
|
-
|
|
Sep 29
2020
|
Boxer Capital, LLC |
BUY
Conversion of derivative security
|
Direct |
1,318,236
+26.01%
|
-
|
|
Sep 25
2020
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
950,000
+50.0%
|
$17,100,000
$18.0 P/Share
|
|
Sep 25
2020
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
950,000
+50.0%
|
$17,100,000
$18.0 P/Share
|